BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31916687)

  • 1. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
    Moore AS; Frimberger AE; Taylor D; Sullivan N
    Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic grading of canine mast cell tumor: is 2 better than 3?
    Sabattini S; Scarpa F; Berlato D; Bettini G
    Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
    Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
    J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic impact of regional lymphadenectomy in canine stage II cutaneous mast cell tumours.
    Marconato L; Polton G; Stefanello D; Morello E; Ferrari R; Henriques J; Tortorella G; Benali SL; Bergottini R; Vasconi ME; Annoni M; Sabattini S
    Vet Comp Oncol; 2018 Dec; 16(4):580-589. PubMed ID: 30047226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
    Berlato D; Murphy S; Laberke S; Rasotto R
    Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
    Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
    Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term postsurgical outcomes of mast cell tumors resected with a margin proportional to the tumor diameter in 23 dogs.
    Itoh T; Kojimoto A; Uchida K; Chambers J; Shii H
    J Vet Med Sci; 2021 Feb; 83(2):230-233. PubMed ID: 33342962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010-2013).
    Risselada M; Mathews KG; Griffith E
    J Am Vet Med Assoc; 2015 Jul; 247(2):184-9. PubMed ID: 26133218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
    Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
    J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone.
    Smith J; Kiupel M; Farrelly J; Cohen R; Olmsted G; Kirpensteijn J; Brocks B; Post G
    Vet Comp Oncol; 2017 Mar; 15(1):36-45. PubMed ID: 25643820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
    Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
    J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation and methylation status of KIT and TP
    Vozdova M; Kubickova S; Fictum P; Cernohorska H; Fröhlich J; Rubes J
    Vet Comp Oncol; 2020 Sep; 18(3):438-444. PubMed ID: 31574575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant medical therapy provides no therapeutic benefit in the treatment of dogs with low-grade mast cell tumours and early nodal metastasis undergoing surgery.
    Marconato L; Stefanello D; Kiupel M; Finotello R; Polton G; Massari F; Ferrari R; Agnoli C; Capitani O; Giudice C; Aresu L; Vasconi ME; Rigillo A; Sabattini S
    Vet Comp Oncol; 2020 Sep; 18(3):409-415. PubMed ID: 31930651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
    Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
    Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous mastocytosis in 8 young dogs and review of literature.
    Yang C; Bradley CW; Preziosi D; Mauldin EA
    Vet Pathol; 2023 Nov; 60(6):849-856. PubMed ID: 37222130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a modified proportional margin approach for complete surgical excision of canine cutaneous mast cell tumours and its association with clinical outcome.
    Saunders H; Thomson MJ; O'Connell K; Bridges JP; Chau L
    Vet Comp Oncol; 2021 Dec; 19(4):604-615. PubMed ID: 32558125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study.
    Ferrari R; Marconato L; Buracco P; Boracchi P; Giudice C; Iussich S; Grieco V; Chiti LE; Favretto E; Stefanello D
    Vet Comp Oncol; 2018 Dec; 16(4):505-510. PubMed ID: 29893066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.